nejm semaglutide cardiovascular New in the May 29, 2025, issue of NEJM: Sotatercept in Pulmonary Arterial Hypertension (ZENITH phase 3 trial) https://nej.md/4iYkLbj Oral and Outcomes (SOUL trial) https://nej.md/4hHII5M Upadacitinib for Giant-Cell Arteritis Nejm semiglutide | PDF

On 2ndDecember 2025, the Delhi High Court declined to grant an interim injunction restraining Dr

Individualization is Key: The ADA strongly advocates tailoring HbA1c goals based on: Duration of diabetes Risk of hypoglycemia Life expectancy Comorbidities (cardiovascular disease, CKD) Patient preference and treatment burden Beyond HbA1c: Modern diabetes care increasingly integrates Continuous Glucose Monitoring (CGM) metrics such as Time in Range (TIR) alongside HbA1c

#GLP1 #ObesityCare #DigitalHealth #PopulationHealth #NovoNordisk #Wegovy #ValueBasedCare

In todays fast-evolving healthcare landscape, few trends are reshaping care delivery as rapidly as telehealth and the rise of GLP-1based treatments for weight management and diabetes

This article del...

Adults with overweight: BMI of 27 or higher, accompanied by weight-related health conditions such as: Type 2 diabetes High blood pressure Sleep apnea Please consult your healthcare provider to determine if Wegovy is suitable for you